David Tornai

12PUBLICATIONS
16CO-AUTHORS
Translation and interpretation studiesPredictive and prognostic markersNutritional epidemiologyInnate immunityEpidemiological methods
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Apr 15, 2026
Letter: Attempted Validation of Villin-1 as a Gut Barrier Marker in Decompensated Cirrhosis-Potential Confounding by Tubular Injury and Aetiology. Authors' Reply.

David Tornai, Maria Papp

|Jan 08, 2026
Editorial: Decoding Gut Failure in Cirrhosis-Villin-1 and the Emergence of a Seventh Organ Failure. Authors' Reply.

David Tornai, Maria Papp

|Dec 04, 2025
Serum Villin-1-A Novel Marker of Gut Barrier Damage in Acutely Decompensated Cirrhosis: A Cohort Study and Validation.

David Tornai, Boglarka Balogh, Aniko Csillag

|Sep 13, 2025
Secretory IgA Is a Key Marker Among Gut Barrier Dysfunction-Related Immunoglobulins Predicting Outcomes in ACLF.

Boglarka Balogh, David Tornai, Aniko Csillag

|Sep 13, 2025
Longitudinal Comparison of Currently Used Risk Scores for Prognostication of Primary Sclerosing Cholangitis (PSC) in a Hungarian Bicenter PSC Cohort.

Peter Laszlo Ven, David Tornai, Bence Toth

|Jul 29, 2025
Hematological Parameter-Derived Inflammatory Scores in Non-Pancreatic Hyperlipasemia (NPHL)-The Prognosis Lies in the Blood.

Krisztina Eszter Feher, David Tornai, Maria Papp

Pageof 2

Frequent Collaborators

5 joint publications

Maria Papp

2 joint publications

Mack Mitchell

2 joint publications

Jonel Trebicka

1 joint publications

Martine Walmsley